Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022

Published on : Jul-2017 | List of Tables : 185 | List of Figures : 69 | No. of Pages : 170 | Report Code : FACT55MR | Format : ppt pdf Excel Word

Breast cancer is a cancer that develops when cells and tissues in the breast begin to grow out of control. Usually forming into a tumor, breast cancer is visible as a lump surrounding the internal breast tissues. Breast cancer tumor is malignant, and occurs almost entirely in women, apart from exceptional occurrences in men.

Fact.MR, in its latest report, estimates the global breast cancer diagnostics market to register a moderate expansion at 4.7% CAGR during the forecast period 2017 to 2022.

Screening Practices of Breast Cancer Witnessed to Alter Early Detection Practices

Breast cancer has become the most common type of cancer for women across the globe. The number of women suffering from breast cancer is witnessing a surge. This has led towards necessity for efficient early detection of breast cancer. Mammography screening, an established method adopted across several countries, has been recently been observed to offer inconclusive test results. Risk-adapted, personalized therapy and screening are predicted to resolve these difficulties. In addition, tomosynthesis, a new imaging technology, has been seen to overcome the drawbacks of mammography.

Screening options for breast cancer have been witnessing a rise, and have been altering practices of early detection across industrialized economies. Moreover, countries such as Brazil, India and China are focusing on development of cost-effective screening strategies capable of being adapted as per requirements.

Market Taxonomy

Test Type

End User

BRCA

Hospital Associated Labs

ER & PR

Independent Diagnostic Laboratories

CEA

Cancer Research Institutes

KRAS Mutation

Others

HER 2

 

PSA

 

CA Test

 

EGFR Mutation Test

 

Immunohistochemistry

 

Others

 

(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)

Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

Competition Tracking

Key market players mentioned in Fact.MR’s report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

Note: The insights mentioned here are of the respective analysts, and do not reflect the position of Fact.MR

Chapter 1 Global Breast Cancer Diagnostics Market - Executive Summary 19

Chapter 2 Global Breast Cancer Diagnostics Market Overview 21
2.1 Introduction 21
    2.1.1 Global Breast Cancer Diagnostics Market Taxonomy 21
    2.1.2 Global Breast Cancer Diagnostics Market Definition 21
2.2 Global Breast Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022 22
    2.2.1 Global Breast Cancer Diagnostics Market Y-o-Y Growth 22
2.3 Global Breast Cancer Diagnostics Market Dynamics 22
    2.3.1 Drivers 22
    2.3.2 Restraints 22
    2.3.3 Trends 23
2.4 Supply Chain 23
2.5 Epidemiology 23
2.6 List of Distributors 23
2.7 Average Pricing Analysis 23
2.8 Regulations 24
2.9 Key Participants Market Presence (Intensity Map) By Region 24

Chapter 3 Global Breast Cancer Diagnostics Market Analysis and Forecast By Test Type 25
3.1 Global Breast Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022 25
    3.1.1 BRCA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 25
          3.1.1.1 Revenue (US$ Mn) Comparison, By Region 25
          3.1.1.2 Market Share Comparison, By Region 26
          3.1.1.3 Y-o-Y growth Comparison, By Region 27
    3.1.2 ER & PR Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 28
          3.1.2.1 Revenue (US$ Mn) Comparison, By Region 28
          3.1.2.2 Market Share Comparison, By Region 29
          3.1.2.3 Y-o-Y growth Comparison, By Region 30
    3.1.3 CEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 31
          3.1.3.1 Revenue (US$ Mn) Comparison, By Region 31
          3.1.3.2 Market Share Comparison, By Region 32
          3.1.3.3 Y-o-Y growth Comparison, By Region 33
    3.1.4 KRAS Mutation Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 34
          3.1.4.1 Revenue (US$ Mn) Comparison, By Region 34
          3.1.4.2 Market Share Comparison, By Region 35
          3.1.4.3 Y-o-Y growth Comparison, By Region 36
    3.1.5 HER 2 Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 37
          3.1.5.1 Revenue (US$ Mn) Comparison, By Region 37
          3.1.5.2 Market Share Comparison, By Region 38
          3.1.5.3 Y-o-Y growth Comparison, By Region 39
    3.1.6 PSA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 40
          3.1.6.1 Revenue (US$ Mn) Comparison, By Region 40
          3.1.6.2 Market Share Comparison, By Region 41
          3.1.6.3 Y-o-Y growth Comparison, By Region 42
    3.1.7 CA Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 43
          3.1.7.1 Revenue (US$ Mn) Comparison, By Region 43
          3.1.7.2 Market Share Comparison, By Region 44
          3.1.7.3 Y-o-Y growth Comparison, By Region 45
    3.1.8 EGFR Mutation Test Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 46
          3.1.8.1 Revenue (US$ Mn) Comparison, By Region 46
          3.1.8.2 Market Share Comparison, By Region 47
          3.1.8.3 Y-o-Y growth Comparison, By Region 48
    3.1.9 Immunohistochemistry Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 49
          3.1.9.1 Revenue (US$ Mn) Comparison, By Region 49
          3.1.9.2 Market Share Comparison, By Region 50
          3.1.9.3 Y-o-Y growth Comparison, By Region 51
    3.1.10 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 52
          3.1.10.1 Revenue (US$ Mn) Comparison, By Region 52
          3.1.10.2 Market Share Comparison, By Region 53
          3.1.10.3 Y-o-Y growth Comparison, By Region 54

Chapter 4 Global Breast Cancer Diagnostics Market Analysis and Forecast By End User 55
4.1 Global Breast Cancer Diagnostics Market Size and Forecast By End User, 2012-2022 55
    4.1.1 Hospital Associated Labs Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 55
          4.1.1.1 Revenue (US$ Mn) Comparison, By Region 55
          4.1.1.2 Market Share Comparison, By Region 57
          4.1.1.3 Y-o-Y growth Comparison, By Region 57
    4.1.2 Independent Diagnostic Laboratories Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 58
          4.1.2.1 Revenue (US$ Mn) Comparison, By Region 58
          4.1.2.2 Market Share Comparison, By Region 60
          4.1.2.3 Y-o-Y growth Comparison, By Region 60
    4.1.3 Cancer Research Institutes Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 61
          4.1.3.1 Revenue (US$ Mn) Comparison, By Region 61
          4.1.3.2 Market Share Comparison, By Region 63
          4.1.3.3 Y-o-Y growth Comparison, By Region 63
    4.1.4 Others Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 64
          4.1.4.1 Revenue (US$ Mn) Comparison, By Region 64
          4.1.4.2 Market Share Comparison, By Region 66
          4.1.4.3 Y-o-Y growth Comparison, By Region 66

Chapter 5 Global Breast Cancer Diagnostics Market Analysis and Forecast By Region 68
5.1 Global Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 68
    5.1.1 North America Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 68
          5.1.1.1 Revenue (US$ Mn) Comparison, By Test Type 68
          5.1.1.2 Revenue (US$ Mn) Comparison, By End User 70
    5.1.2 Latin America Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 72
          5.1.2.1 Revenue (US$ Mn) Comparison, By Test Type 72
          5.1.2.2 Revenue (US$ Mn) Comparison, By End User 74
    5.1.3 Europe Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 76
          5.1.3.1 Revenue (US$ Mn) Comparison, By Test Type 76
          5.1.3.2 Revenue (US$ Mn) Comparison, By End User 78
    5.1.4 Japan Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 80
          5.1.4.1 Revenue (US$ Mn) Comparison, By Test Type 80
          5.1.4.2 Revenue (US$ Mn) Comparison, By End User 82
    5.1.5 APEJ Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 84
          5.1.5.1 Revenue (US$ Mn) Comparison, By Test Type 84
          5.1.5.2 Revenue (US$ Mn) Comparison, By End User 86
    5.1.6 MEA Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 88
          5.1.6.1 Revenue (US$ Mn) Comparison, By Test Type 88
          5.1.6.2 Revenue (US$ Mn) Comparison, By End User 90

Chapter 6 North America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 92
6.1 US Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 92
    6.1.1 Revenue (US$ Mn) Comparison, By Test Type 92
    6.1.2 Revenue (US$ Mn) Comparison, By End User 93
6.2 Canada Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 94
    6.2.1 Revenue (US$ Mn) Comparison, By Test Type 94
    6.2.2 Revenue (US$ Mn) Comparison, By End User 95

Chapter 7 Latin America Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 96
7.1 Brazil Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 96
    7.1.1 Revenue (US$ Mn) Comparison, By Test Type 96
    7.1.2 Revenue (US$ Mn) Comparison, By End User 97
7.2 Mexico Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 98
    7.2.1 Revenue (US$ Mn) Comparison, By Test Type 98
    7.2.2 Revenue (US$ Mn) Comparison, By End User 99
7.3 Argentina Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 100
    7.3.1 Revenue (US$ Mn) Comparison, By Test Type 100
    7.3.2 Revenue (US$ Mn) Comparison, By End User 101

Chapter 8 Europe Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 102
8.1 Germany Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 102
    8.1.1 Revenue (US$ Mn) Comparison, By Test Type 102
    8.1.2 Revenue (US$ Mn) Comparison, By End User 103
8.2 UK Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 104
    8.2.1 Revenue (US$ Mn) Comparison, By Test Type 104
    8.2.2 Revenue (US$ Mn) Comparison, By End User 105
8.3 France Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 106
    8.3.1 Revenue (US$ Mn) Comparison, By Test Type 106
    8.3.2 Revenue (US$ Mn) Comparison, By End User 107
8.4 Spain Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 108
    8.4.1 Revenue (US$ Mn) Comparison, By Test Type 108
    8.4.2 Revenue (US$ Mn) Comparison, By End User 109
8.5 Italy Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 110
    8.5.1 Revenue (US$ Mn) Comparison, By Test Type 110
    8.5.2 Revenue (US$ Mn) Comparison, By End User 111
8.6 Nordic Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 112
    8.6.1 Revenue (US$ Mn) Comparison, By Test Type 112
    8.6.2 Revenue (US$ Mn) Comparison, By End User 113

Chapter 9 Japan Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 114
9.1 Japan Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 114
    9.1.1 Revenue (US$ Mn) Comparison, By Test Type 114
    9.1.2 Revenue (US$ Mn) Comparison, By End User 115

Chapter 10 APEJ Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 116
10.1 China Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 116
    10.1.1 Revenue (US$ Mn) Comparison, By Test Type 116
    10.1.2 Revenue (US$ Mn) Comparison, By End User 117
10.2 India Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 118
    10.2.1 Revenue (US$ Mn) Comparison, By Test Type 118
    10.2.2 Revenue (US$ Mn) Comparison, By End User 119
10.3 Malaysia Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 120
    10.3.1 Revenue (US$ Mn) Comparison, By Test Type 120
    10.3.2 Revenue (US$ Mn) Comparison, By End User 121
10.4 Thailand Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 122
    10.4.1 Revenue (US$ Mn) Comparison, By Test Type 122
    10.4.2 Revenue (US$ Mn) Comparison, By End User 123
10.5 Singapore Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 124
    10.5.1 Revenue (US$ Mn) Comparison, By Test Type 124
    10.5.2 Revenue (US$ Mn) Comparison, By End User 125
10.6 Australia Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 126
    10.6.1 Revenue (US$ Mn) Comparison, By Test Type 126
    10.6.2 Revenue (US$ Mn) Comparison, By End User 127

Chapter 11 MEA Breast Cancer Diagnostics Market Analysis and Forecast, By Country, 2012-2022 128
11.1 GCC Countries Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 128
    11.1.1 Revenue (US$ Mn) Comparison, By Test Type 128
    11.1.2 Revenue (US$ Mn) Comparison, By End User 129
11.2 South Africa Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 130
    11.2.1 Revenue (US$ Mn) Comparison, By Test Type 130
    11.2.2 Revenue (US$ Mn) Comparison, By End User 131
11.3 Nigeria Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 132
    11.3.1 Revenue (US$ Mn) Comparison, By Test Type 132
    11.3.2 Revenue (US$ Mn) Comparison, By End User 133
11.4 Israel Breast Cancer Diagnostics Market Size and Forecast, 2012-2022 134
    11.4.1 Revenue (US$ Mn) Comparison, By Test Type 134
    11.4.2 Revenue (US$ Mn) Comparison, By End User 135

Chapter 12 Company Profiles 136
12.1 Abbott Laboratories 136
    12.1.1 Company Overview 136
    12.1.2 Product Overview: 136
    12.1.3 Key Financials: 137
    12.1.4 SWOT Analysis 137
    12.1.5 Key Developments 137
12.2 Roche Holding AG. 138
    12.2.1 Company Overview 138
    12.2.2 Product Overview: 138
    12.2.3 Key Financials: 139
    12.2.4 Key Developments 139
12.3 Thermo Fisher Scientific Inc. 142
    12.3.1 Company Overview 142
    12.3.2 Product Overview: 142
    12.3.3 Key Financials: 143
    12.3.4 SWOT Analysis 143
    12.3.5 Key Developments 143
12.4 Siemens AG 144
    12.4.1 Company Overview 144
    12.4.2 Product Overview: 144
    12.4.3 Key Financials: 145
    12.4.4 SWOT Analysis 145
    12.4.5 Key Developments 145
12.5 Bio-Rad Laboratories, Inc. 146
    12.5.1 Company Overview 146
    12.5.2 Product Overview: 146
    12.5.3 SWOT Analysis 147
    12.5.4 Key Developments 149
12.6 Illumina, Inc. 150
    12.6.1 Company Overview 150
    12.6.2 Product Overview: 150
    12.6.3 Key Financials: 151
    12.6.4 SWOT Analysis 151
12.6.5 Key Development 151
12.7 Biocept, Inc. 152
    12.7.1 Company Overview 152
    12.7.2 Product Overview: 152
    12.7.3 Key Financials 153
    12.7.4 Key Developments 153
12.8 AstraZeneCA plc 154
    12.8.1 Company Overview 154
    12.8.2 Product Overview: 154
    12.8.3 Key Financials 154
    12.8.4 Key Developments 154
    12.8.5 SWOT Analysis 155
12.9 Myriad Genetics Inc 159
    12.9.1 Company Overview 159
    12.9.2 Product Overview 159
    12.9.3 Key Financials 160
    12.9.4 SWOT Analysis 160
12.10 Quest Diagnostics Incorporated 164
    12.10.1 Company Overview 164
    12.10.2 Product Overview 164
    12.10.3 Key Financials 165
    12.10.4 SWOT Analysis 165

Chapter 13 Disclaimer and Contact information 168

TABLE 1 Global Breast Cancer Diagnostics Market Value (US$ Mn), 2012-2016 17
TABLE 2 Global Breast Cancer Diagnostics Market Value (US$ Mn), 2017-2022 18
TABLE 3 Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022Value (US$ Mn) 20
TABLE 4 Global BRCA Segment Value (US$ Mn), By Region 2012-2016 23
TABLE 5 Global BRCA Segment Value (US$ Mn), By Region 2017-2022 23
TABLE 6 Global BRCA Segment Market Share, By Region 2012-2016 24
TABLE 7 Global BRCA Segment Market Share, By Region 2017-2022 25
TABLE 8 Global BRCA Segment Y-o-Y, By Region 2015-2022 25
TABLE 9 Global ER & PR Segment Value (US$ Mn), By Region 2012-2016 26
TABLE 10 Global ER & PR Segment Value (US$ Mn), By Region 2017-2022 26
TABLE 11 Global ER & PR Segment Market Share, By Region 2012-2016 27
TABLE 12 Global ER & PR Segment Market Share, By Region 2017-2022 28
TABLE 13 Global ER & PR Segment Y-o-Y, By Region 2015-2022 28
TABLE 14 Global CEA Segment Value (US$ Mn), By Region 2012-2016 29
TABLE 15 Global CEA Segment Value (US$ Mn), By Region 2017-2022 29
TABLE 16 Global CEA Segment Market Share, By Region 2012-2016 30
TABLE 17 Global CEA Segment Market Share, By Region 2017-2022 31
TABLE 18 Global CEA Segment Y-o-Y, By Region 2015-2022 31
TABLE 19 Global KRAS Mutation Segment Value (US$ Mn), By Region 2012-2016 32
TABLE 20 Global KRAS Mutation Segment Value (US$ Mn), By Region 2017-2022 32
TABLE 21 Global KRAS Mutation Segment Market Share, By Region 2012-2016 33
TABLE 22 Global KRAS Mutation Segment Market Share, By Region 2017-2022 34
TABLE 23 Global KRAS Mutation Segment Y-o-Y, By Region 2015-2022 34
TABLE 24 Global HER 2 Segment Value (US$ Mn), By Region 2012-2016 35
TABLE 25 Global HER 2 Segment Value (US$ Mn), By Region 2017-2022 35
TABLE 26 Global HER 2 Segment Market Share, By Region 2012-2016 36
TABLE 27 Global HER 2 Segment Market Share, By Region 2017-2022 37
TABLE 28 Global HER 2 Segment Y-o-Y, By Region 2015-2022 37
TABLE 29 Global PSA Segment Value (US$ Mn), By Region 2012-2016 38
TABLE 30 Global PSA Segment Value (US$ Mn), By Region 2017-2022 38
TABLE 31 Global PSA Segment Market Share, By Region 2012-2016 39
TABLE 32 Global PSA Segment Market Share, By Region 2017-2022 40
TABLE 33 Global PSA Segment Y-o-Y, By Region 2015-2022 40
TABLE 34 Global CA Test Segment Value (US$ Mn), By Region 2012-2016 41
TABLE 35 Global CA Test Segment Value (US$ Mn), By Region 2017-2022 41
TABLE 36 Global CA Test Segment Market Share, By Region 2012-2016 42
TABLE 37 Global CA Test Segment Market Share, By Region 2017-2022 43
TABLE 38 Global CA Test Segment Y-o-Y, By Region 2015-2022 43
TABLE 39 Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2012-2016 44
TABLE 40 Global EGFR Mutation Test Segment Value (US$ Mn), By Region 2017-2022 44
TABLE 41 Global EGFR Mutation Test Segment Market Share, By Region 2012-2016 45
TABLE 42 Global EGFR Mutation Test Segment Market Share, By Region 2017-2022 46
TABLE 43 Global EGFR Mutation Test Segment Y-o-Y, By Region 2015-2022 46
TABLE 44 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2012-2016 47
TABLE 45 Global Immunohistochemistry Segment Value (US$ Mn), By Region 2017-2022MEA 47
TABLE 46 Global Immunohistochemistry Segment Market Share, By Region 2012-2016 48
TABLE 47 Global Immunohistochemistry Segment Market Share, By Region 2017-2022 49
TABLE 48 Global Immunohistochemistry Segment Y-o-Y, By Region 2015-2022 49
TABLE 49 Global Others Segment Value (US$ Mn), By Region 2012-2016 50
TABLE 50 Global Others Segment Value (US$ Mn), By Region 2017-2022 50
TABLE 51 Global Others Segment Market Share, By Region 2012-2016 51
TABLE 52 Global Others Segment Market Share, By Region 2017-2022 52
TABLE 53 Global Others Segment Y-o-Y, By Region 2015-2022 52
TABLE 54 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2012-2016 53
TABLE 55 Global Hospital Associated Labs Segment Value (US$ Mn), By Region 2017-2022 54
TABLE 56 Global Hospital Associated Labs Segment Market Share, By Region 2012-2016 55
TABLE 57 Global Hospital Associated Labs Segment Market Share, By Region 2017-2022 55
TABLE 58 Global Hospital Associated Labs Segment Y-o-Y, By Region 2015-2022 55
TABLE 59 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2012-2016 56
TABLE 60 Global Independent Diagnostic Laboratories Segment Value (US$ Mn), By Region 2017-2022 57
TABLE 61 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2012-2016 58
TABLE 62 Global Independent Diagnostic Laboratories Segment Market Share, By Region 2017-2022 58
TABLE 63 Global Independent Diagnostic Laboratories Segment Y-o-Y, By Region 2015-2022 58
TABLE 64 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2012-2016 59
TABLE 65 Global Cancer Research Institutes Segment Value (US$ Mn), By Region 2017-2022 60
TABLE 66 Global Cancer Research Institutes Segment Market Share, By Region 2012-2016 61
TABLE 67 Global Cancer Research Institutes Segment Market Share, By Region 2017-2022 61
TABLE 68 Global Cancer Research Institutes Segment Y-o-Y, By Region 2015-2022 61
TABLE 69 Global Others Segment Value (US$ Mn), By Region 2012-2016 62
TABLE 70 Global Others Segment Value (US$ Mn), By Region 2017-2022 63
TABLE 71 Global Others Segment Market Share, By Region 2012-2016 64
TABLE 72 Global Others Segment Market Share, By Region 2017-2022 64
TABLE 73 Global Others Segment Y-o-Y, By Region 2015-2022 64
TABLE 74 North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 66
TABLE 75 North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 67
TABLE 76 North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 68
TABLE 77 North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 68
TABLE 78 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 70
TABLE 79 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 71
TABLE 80 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 72
TABLE 81 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 72
TABLE 82 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 74
TABLE 83 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 75
TABLE 84 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 76
TABLE 85 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 76
TABLE 86 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 78
TABLE 87 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 79
TABLE 88 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 80
TABLE 89 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 80
TABLE 90 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 82
TABLE 91 Source: FactMR, 2017APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 83
TABLE 92 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 84
TABLE 93 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 84
TABLE 94 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 86
TABLE 95 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 87
TABLE 96 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 88
TABLE 97 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 88
TABLE 98 US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 90
TABLE 99 US Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 90
TABLE 100 US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 91
TABLE 101 US Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 91
TABLE 102 Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 92
TABLE 103 Canada Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 92
TABLE 104 Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 93
TABLE 105 Canada Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 93
TABLE 106 Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 94
TABLE 107 Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 94
TABLE 108 Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 95
TABLE 109 Brazil Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 95
TABLE 110 Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 96
TABLE 111 Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 96
TABLE 112 Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 97
TABLE 113 Mexico Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 97
TABLE 114 Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 98
TABLE 115 Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 98
TABLE 116 Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 99
TABLE 117 Argentina Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 99
TABLE 118 Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 100
TABLE 119 Germany Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 100
TABLE 120 Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 101
TABLE 121 Germany Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 101
TABLE 122 UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 102
TABLE 123 UK Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 102
TABLE 124 UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 103
TABLE 125 UK Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 103
TABLE 126 France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 104
TABLE 127 France Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 104
TABLE 128 France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 105
TABLE 129 France Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 105
TABLE 130 Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 106
TABLE 131 Spain Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 106
TABLE 132 Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 107
TABLE 133 Spain Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 107
TABLE 134 Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 108
TABLE 135 Italy Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 108
TABLE 136 Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 109
TABLE 137 Italy Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 109
TABLE 138 Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 110
TABLE 139 Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 110
TABLE 140 Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 111
TABLE 141 Nordic Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 111
TABLE 142 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 112
TABLE 143 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 112
TABLE 144 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 113
TABLE 145 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 113
TABLE 146 China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 114
TABLE 147 China Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 114
TABLE 148 China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 115
TABLE 149 China Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 115
TABLE 150 India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 116
TABLE 151 India Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 116
TABLE 152 India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 117
TABLE 153 India Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 117
TABLE 154 Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 118
TABLE 155 Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 118
TABLE 156 Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 119
TABLE 157 Malaysia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 119
TABLE 158 Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 120
TABLE 159 Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 120
TABLE 160 Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 121
TABLE 161 Thailand Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 121
TABLE 162 Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 122
TABLE 163 Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 122
TABLE 164 Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 123
TABLE 165 Singapore Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 123
TABLE 166 Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 124
TABLE 167 Australia Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 124
TABLE 168 Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 125
TABLE 169 Australia Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 125
TABLE 170 GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 126
TABLE 171 GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 126
TABLE 172 GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 127
TABLE 173 GCC Countries Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 127
TABLE 174 South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 128
TABLE 175 South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 128
TABLE 176 South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 129
TABLE 177 South Africa Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 129
TABLE 178 Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 130
TABLE 179 Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 130
TABLE 180 Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 131
TABLE 181 Nigeria Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 131
TABLE 182 Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 132
TABLE 183 Israel Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 132
TABLE 184 Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 133
TABLE 185 Israel Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 133

FIG. 1 Global Breast Cancer Diagnostics Market Value (US$ Mn), 2012-2016: Global Breast Cancer Value), 2017-2022Value (US$ Mn) 10
FIG. 2 Breast Cancer Diagnostics Market Value (US$ Mn) Forecast, 2017-2022 10
FIG. 3 Global Breast Cancer Diagnostics Market Value (US$ Mn) and Y-o-Y, 2015-2022 12
FIG. 4 Global BRCA Segment Market Value (US$ Mn) By Region, 2012-2016 15
FIG. 5 Global BRCA Segment Market Value (US$ Mn) By Region, 2017-2022 16
FIG. 6 Global BRCA Segment Y-o-Y Growth Rate, By Region, 2015-2022 17
FIG. 7 Global ER & PR Segment Market Value (US$ Mn) By Region, 2012-2016 18
FIG. 8 Global ER & PR Segment Market Value (US$ Mn) By Region, 2017-2022 19
FIG. 9 Global ER & PR Segment Y-o-Y Growth Rate, By Region, 2015-2022 20
FIG. 10 Global CEA Segment Market Value (US$ Mn) By Region, 2012-2016 21
FIG. 11 Global CEA Segment Market Value (US$ Mn) By Region, 2017-2022 22
FIG. 12 Global CEA Segment Y-o-Y Growth Rate, By Region, 2015-2022 23
FIG. 13 Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2012-2016 24
FIG. 14 Global KRAS Mutation Segment Market Value (US$ Mn) By Region, 2017-2022 25
FIG. 15 Global KRAS Mutation Segment Y-o-Y Growth Rate, By Region, 2015-2022 26
FIG. 16 Global HER 2 Segment Market Value (US$ Mn) By Region, 2012-2016 27
FIG. 17 Global HER 2 Segment Market Value (US$ Mn) By Region, 2017-2022 28
FIG. 18 Global HER 2 Segment Y-o-Y Growth Rate, By Region, 2015-2022 29
FIG. 19 Global PSA Segment Market Value (US$ Mn) By Region, 2012-2016 30
FIG. 20 Global PSA Segment Market Value (US$ Mn) By Region, 2017-2022 31
FIG. 21 Global PSA Segment Y-o-Y Growth Rate, By Region, 2015-2022 32
FIG. 22 Global CA Test Segment Market Value (US$ Mn) By Region, 2012-2016 33
FIG. 23 Global CA Test Segment Market Value (US$ Mn) By Region, 2017-2022 34
FIG. 24 Global CA Test Segment Y-o-Y Growth Rate, By Region, 2015-2022 35
FIG. 25 Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2012-2016 36
FIG. 26 Global EGFR Mutation Test Segment Market Value (US$ Mn) By Region, 2017-2022 37
FIG. 27 Global EGFR Mutation Test Segment Y-o-Y Growth Rate, By Region, 2015-2022 38
FIG. 28 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2012-2016 39
FIG. 29 Global Immunohistochemistry Segment Market Value (US$ Mn) By Region, 2017-2022 40
FIG. 30 Global Immunohistochemistry Segment Y-o-Y Growth Rate, By Region, 2015-2022 41
FIG. 31 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 42
FIG. 32 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 43
FIG. 33 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 44
FIG. 34 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2012-2016 45
FIG. 35 Global Hospital Associated Labs Segment Market Value (US$ Mn) By Region, 2017-2022 46
FIG. 36 Global Hospital Associated Labs Segment Y-o-Y Growth Rate, By Region, 2015-2022 48
FIG. 37 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2012-2016 48
FIG. 38 Global Independent Diagnostic Laboratories Segment Market Value (US$ Mn) By Region, 2017-2022 49
FIG. 39 Global Independent Diagnostic Laboratories Segment Y-o-Y Growth Rate, By Region, 2015-2022 51
FIG. 40 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2012-2016 51
FIG. 41 Global Cancer Research Institutes Segment Market Value (US$ Mn) By Region, 2017-2022 52
FIG. 42 Global Cancer Research Institutes Segment Y-o-Y Growth Rate, By Region, 2015-2022 54
FIG. 43 Global Others Segment Market Value (US$ Mn) By Region, 2012-2016 54
FIG. 44 Global Others Segment Market Value (US$ Mn) By Region, 2017-2022 55
FIG. 45 Global Others Segment Y-o-Y Growth Rate, By Region, 2015-2022 57
FIG. 46 North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 58
FIG. 47 North America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 59
FIG. 48 North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 60
FIG. 49 North America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 61
FIG. 50 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 62
FIG. 51 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 63
FIG. 52 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 64
FIG. 53 Latin America Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 65
FIG. 54 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 66
FIG. 55 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 67
FIG. 56 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 68
FIG. 57 Europe Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 69
FIG. 58 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 70
FIG. 59 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 71
FIG. 60 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 72
FIG. 61 Japan Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 73
FIG. 62 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 74
FIG. 63 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 75
FIG. 64 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 76
FIG. 65 APEJ Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 77
FIG. 66 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2012-2016 78
FIG. 67 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By Test Type 2017-2022 79
FIG. 68 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2012-2016 80
FIG. 69 MEA Breast Cancer Diagnostics Market Value (US$ Mn), By End User 2017-2022 81

Fact.MR offers custom research services that help clients to get specific research solutions

We are committed towards customer satisfaction and quality service.


Our Clients

Malaysian Cocoa Board
Dunlop International Europe Ltd
Roland Berger
Superior Essex
Commscope
Deloitte

Fact.MR in Media

Breast Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Market insights 2017 to 2022